Compound Evidence File
#EC-2026-0899
AHK-CU
Filed under Peptides. The bureau holds 178 laboratory returns for this compound from 71 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
71 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 4 Mar 2026 | 2 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Nov 2025 | 11 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Mar 2026 | 5 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 9.9 | 10.0 | 5 Dec 2025 | 23 Apr 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 15 Jan 2026 | 13 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 17 May 2026 | 2 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Dec 2025 | 20 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 6 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Mar 2026 | 18 Aug 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 4 Apr 2026 | 2 Jun 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Jul 2025 | 2 Jul 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 7 | 9.9 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 16 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 28 May 2026 | 23 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Mar 2026 | 10 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 9.9 | 14 Dec 2025 | 2 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 20 Jan 2026 | 17 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 9.9 | 9.9 | 9.9 | 14 Nov 2025 | 26 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 9.9 | 18 Jan 2026 | 8 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 27 Feb 2026 | 13 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 15 May 2026 | 9 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 7 Jun 2026 | 17 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Jun 2026 | 10 Aug 2026 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 9.7 | 9.7 | 9.7 | 7 May 2025 | 7 May 2025 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 9.4 | 9.4 | 9.4 | 8 Jul 2025 | 8 Jul 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 9.2 | 9.2 | 9.2 | 20 Jun 2025 | 20 Jun 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 2 | 9.1 | 8.1 | 10.0 | 13 Jun 2025 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.8 | 7.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.8 | 8.8 | 8.9 | 21 May 2026 | 21 May 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 8.8 | 8.8 | 8.8 | 9 Jun 2025 | 9 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.6 | 8.2 | 9.4 | 21 May 2026 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.3 | 7.3 | 9.7 | 21 May 2026 | 21 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 8.3 | 8.3 | 8.3 | 24 Apr 2025 | 24 Apr 2025 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 8.3 | 8.3 | 8.3 | 28 Mar 2025 | 28 Mar 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 8.1 | 7.1 | 9.0 | 23 May 2026 | 23 May 2026 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 4 | 8.1 | 6.1 | 9.0 | 8 Jul 2025 | 24 May 2026 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 8.0 | 8.0 | 8.0 | 8 Jul 2025 | 8 Jul 2025 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 2 | 7.8 | 7.6 | 7.9 | 2 Jul 2025 | 23 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 4 | 7.7 | 4.9 | 10.0 | 13 Feb 2025 | 24 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 6 | 7.5 | 5.7 | 9.0 | 16 Mar 2025 | 19 Jan 2026 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 7 | 7.3 | 4.9 | 9.4 | 28 Mar 2025 | 20 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 7.2 | 7.2 | 7.2 | 16 Mar 2025 | 16 Mar 2025 |
| Atomik LabzCASE #VI-2026-0327 | X | 3 | 7.0 | 6.5 | 7.3 | 2 Apr 2025 | 19 Jan 2026 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 7.0 | 7.0 | 7.0 | 11 Jun 2025 | 11 Jun 2025 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 6.9 | 6.9 | 6.9 | 20 Jun 2025 | 20 Jun 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 6.7 | 6.7 | 6.7 | 2 Jul 2025 | 2 Jul 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 6.5 | 6.5 | 6.5 | 27 Feb 2025 | 27 Feb 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 2 | 6.4 | 5.1 | 7.7 | 3 Jun 2025 | 17 May 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 1 | 6.3 | 6.3 | 6.3 | 2 Apr 2025 | 2 Apr 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 3 | 6.0 | 4.8 | 6.9 | 16 Mar 2025 | 23 May 2026 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 6.0 | 6.0 | 6.0 | 20 Jun 2025 | 20 Jun 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 5 | 5.9 | 3.5 | 8.6 | 24 Apr 2025 | 17 May 2026 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 5.9 | 5.9 | 5.9 | 2 Jul 2025 | 2 Jul 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | E | 2 | 5.8 | 5.2 | 6.5 | 2 Apr 2025 | 25 May 2026 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 5.7 | 5.7 | 5.7 | 20 Jun 2025 | 20 Jun 2025 |
| NextechLabsCASE #VI-2026-0285 | X | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 | 13 Feb 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 3 | 5.4 | 4.1 | 7.1 | 25 Apr 2025 | 26 Jan 2026 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 5.0 | 5.0 | 5.0 | 28 Mar 2025 | 28 Mar 2025 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 5.0 | 5.0 | 5.0 | 3 Jul 2025 | 3 Jul 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 2 | 4.8 | 2.3 | 7.3 | 8 Jul 2025 | 19 Jan 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 4.7 | 4.7 | 4.7 | 20 Jun 2025 | 20 Jun 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 2 | 4.6 | 4.5 | 4.7 | 2 Apr 2025 | 24 May 2026 |
| YimeiCASE #VI-2026-0081 | X | 1 | 4.1 | 4.1 | 4.1 | 21 May 2025 | 21 May 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 1 | 2.9 | 2.9 | 2.9 | 2 Jul 2025 | 2 Jul 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 2.4 | 2.4 | 2.4 | 13 Feb 2025 | 13 Feb 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 1.7 | 1.7 | 1.7 | 3 Jul 2025 | 3 Jul 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 1.1 | 1.1 | 1.1 | 28 Mar 2025 | 28 Mar 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 1.0 | 1.0 | 1.0 | 20 Jun 2025 | 20 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
Open any subject to view the batch-level evidence for AHK-CU alone.